PNV 3.09% $2.51 polynovo limited

Ann: AGM - Chairman and CEO address to shareholders, page-51

  1. 16,667 Posts.
    lightbulb Created with Sketch. 2377
    I think when the results of the completed BARDA trial are analysed and reported then it will have significant benefits for reimbursement in the US and improve awareness, confidence and marketshare. IMO the US military who I believe already use it through VA hospitals will likely consider it's wider appeal as reports are published of reatment in war zone victims.
    Something to look forward to in supporting and driving growth.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.51
Change
-0.080(3.09%)
Mkt cap ! $1.722B
Open High Low Value Volume
$2.58 $2.58 $2.47 $2.393M 949.1K

Buyers (Bids)

No. Vol. Price($)
33 28291 $2.50
 

Sellers (Offers)

Price($) Vol. No.
$2.51 1537 4
View Market Depth
Last trade - 14.23pm 18/07/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.